Cargando…

Chronic opioid use and complication risks in women with endometriosis: A cohort study in US administrative claims

BACKGROUND: Women with endometriosis are prescribed opioids for pain relief but may be vulnerable to chronic opioid use given their comorbidity profile. METHODS: A cohort study was conducted in the Clinformatics™ DataMart database between 2006 and 2017 comparing women aged 18–50 years with endometri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiuve, Stephanie E., Kilpatrick, Ryan D., Hornstein, Mark D., Petruski‐Ivleva, Natalia, Wegrzyn, Lani R., Dabrowski, Elizabeth C., Velentgas, Priscilla, Snabes, Michael C., Bateman, Brian T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251707/ https://www.ncbi.nlm.nih.gov/pubmed/33611812 http://dx.doi.org/10.1002/pds.5209

Ejemplares similares

Chronic kidney disease progression among patients with type 2 diabetes identified in US administrative claims: a population cohort study
por: Kovesdy, Csaba P, et al.
Publicado: (2020)

Depression, Anxiety, and Self-Directed Violence in Women With Endometriosis: A Retrospective Matched-Cohort Study
por: Estes, Stephanie J, et al.
Publicado: (2020)

Healthcare Service Use Patterns Among Patients with Acid Sphingomyelinase Deficiency Type B: A Retrospective US Claims Analysis
por: Pulikottil-Jacob, Ruth, et al.
Publicado: (2023)

Estimating the Effect of Elagolix Treatment for Endometriosis on Postmenopausal Bone Outcomes: A Model Bridging Phase III Trials to an Older Real‐World Population
por: Kilpatrick, Ryan D, et al.
Publicado: (2020)

Annual health care resource utilization and cost among type 2 diabetes patients with newly recognized chronic kidney disease within a large U.S. administrative claims database
por: Folkerts, Kerstin, et al.
Publicado: (2020)

Uterine fibroids and incidence of depression, anxiety and self-directed violence: a cohort study
por: Chiuve, Stephanie E, et al.
Publicado: (2022)

Actuarial Analysis of Private Payer Administrative Claims Data for Women With Endometriosis
por: Mirkin, David, et al.
Publicado: (2007)

Endometriosis and Opioid Receptors: Are Opioids a Possible/Promising Treatment for Endometriosis?
por: Guan, Qihui, et al.
Publicado: (2023)

Identification of a Vulnerable Group for Post-Acute Sequelae of SARS-CoV-2 (PASC): People with Autoimmune Diseases Recover More Slowly from COVID-19
por: Dreyer, Nancy, et al.
Publicado: (2021)

Development and Validation of an Algorithm to Identify Endometrial Adenocarcinoma in US Administrative Claims Data
por: Esposito, D. B., et al.
Publicado: (2019)

Identification of pregnancies and infants within a US commercial healthcare administrative claims database
por: Bertoia, Monica L., et al.
Publicado: (2022)

Analysis of dementia in the US population using Medicare claims: Insights from linked survey and administrative claims data
por: Chen, Yi, et al.
Publicado: (2019)

Clinical features and diagnosis of multiple myeloma: a population-based cohort study in primary care
por: Seesaghur, Anouchka, et al.
Publicado: (2021)

Psychometric assessment of the PROMIS Fatigue Short Form 6a in women with moderate-to-severe endometriosis-associated pain
por: Pokrzywinski, Robin, et al.
Publicado: (2020)

Real-World Characterization of Women with Diagnosed Endometriosis Initiating Therapy with Elagolix Using a US Claims Database
por: Surrey, Eric S, et al.
Publicado: (2020)

Persistence and Compliance with Pazopanib in Patients with Advanced Renal Cell Carcinoma Within a U.S. Administrative Claims Database
por: Hackshaw, Michelle D., et al.
Publicado: (2014)

Health-Related Quality of Life Improvements in Patients With Endometriosis Treated With Elagolix
por: Taylor, Hugh S., et al.
Publicado: (2020)

Patient-completed or symptom-based screening tools for endometriosis: a scoping review
por: Surrey, Eric, et al.
Publicado: (2017)

The United States Drug Enforcement Administration and Prescription Opioid Production Quotas: An End Game of Eradication?
por: Schatman, Michael E, et al.
Publicado: (2020)

Changes in Healthcare Spending After Diagnosis of Comorbidities Among Endometriosis Patients: A Difference-in-Differences Analysis
por: Epstein, Andrew J., et al.
Publicado: (2017)

Milk Intake at Midlife and Cognitive Decline over 20 Years. The Atherosclerosis Risk in Communities (ARIC) Study
por: Petruski-Ivleva, Natalia, et al.
Publicado: (2017)

Self-reported symptoms from exposure to Covid-19 provide support to clinical diagnosis, triage and prognosis: An exploratory analysis
por: Dreyer, Nancy A., et al.
Publicado: (2020)

The GRACE Checklist: A Validated Assessment Tool for High Quality Observational Studies of Comparative Effectiveness
por: Dreyer, Nancy A., et al.
Publicado: (2016)

Association of the 2016 US Centers for Disease Control and Prevention Opioid Prescribing Guideline With Changes in Opioid Dispensing After Surgery
por: Sutherland, Tori N., et al.
Publicado: (2021)

Disease burden and cost of hidradenitis suppurativa: a retrospective examination of US administrative claims data
por: Marvel, Jessica, et al.
Publicado: (2019)

Reductions in endometriosis-associated pain among women treated with elagolix are consistent across a range of baseline characteristics reflective of real-world patients
por: Abrao, Mauricio S., et al.
Publicado: (2021)

Corrigendum to “Systematic comparisons between Lyme disease and post-treatment Lyme disease syndrome in the U.S. with administrative claims data”
por: Chung, Ming Kei, et al.
Publicado: (2023)

Estimating the Costs of Opioid Abuse and Dependence from an Employer Perspective: a Retrospective Analysis Using Administrative Claims Data
por: Rice, J. Bradford, et al.
Publicado: (2014)

Real‐world reproducibility study characterizing patients newly diagnosed with multiple myeloma using Clinical Practice Research Datalink, a UK‐based electronic health records database
por: Seesaghur, Anouchka, et al.
Publicado: (2020)

510. Real-world Effectiveness of Sotrovimab for COVID-19: Evidence from United States (US) Administrative Claims Data
por: Bell, Christopher F, et al.
Publicado: (2023)

Low rates of patient-reported outcome claims for orphan drugs approved by the us food and drug administration
por: Jarosławski, Szymon, et al.
Publicado: (2018)

Predictors of latent tuberculosis infection treatment completion in the US private sector: an analysis of administrative claims data
por: Stockbridge, Erica L., et al.
Publicado: (2018)

Cost of peripheral neuropathy in patients receiving treatment for multiple myeloma: a US administrative claims analysis
por: Song, Xue, et al.
Publicado: (2019)

RWD106 Characterizing Telehealth Utilization from Administrative Claims in the US Using a Standardized Definition
por: Avula, R, et al.
Publicado: (2022)

Opioid Administration and Prescribing in Older Adults in U.S. Emergency Departments (2005–2015)
por: Marra, Erin M., et al.
Publicado: (2018)

The GRACE Checklist for Rating the Quality of Observational Studies of Comparative Effectiveness: A Tale of Hope and Caution
por: Dreyer, Nancy A., et al.
Publicado: (2014)

Correction to: Development and Validation of ICD‑10‑CM‑based Algorithms for Date of Last Menstrual Period, Pregnancy Outcomes, and Infant Outcomes
por: Chomistek, Andrea K., et al.
Publicado: (2023)

Development and Validation of ICD-10-CM-based Algorithms for Date of Last Menstrual Period, Pregnancy Outcomes, and Infant Outcomes
por: Chomistek, Andrea K., et al.
Publicado: (2023)

Development and Validation of an Inflammatory Bowel Disease Severity Index Using US Administrative Claims Data: A Retrospective Cohort Study
por: Chen, Grace, et al.
Publicado: (2020)

The COX-2-specific inhibitor parecoxib sodium is opioid-sparing and improves pain relief as part of a multimodal treatment strategy
por: Camu, F, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_gauui702i3q48fg5ggehaaopba